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POSITION STATEMENT
conjunction with lifestyle modifications will remain the
treatment of choice for acute menopausal symptoms for the
immediate future. It is hoped that future research will be able
to identify a patient profile or method of application where
longer use of HT is without risk. This will unlock the true
potential of HT in the prevention and treatment of osteoporosis
and allow new research on the role of HT in primary
prevention.
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This statement was prepared under the chairmanship of Dr T J
de Villiers. It was reviewed by the Council of SAMS during July
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SCIENTIFIC LETTER
To the Editor: One of the key recommendations of the Second
Report on Confidential Enquiries into Maternal Deaths in South
Africa 1999 - 2001, was that regional anaesthesia (RA) ‘should
be promoted in all sites performing caesarean sections’ (CSs). A
target was given for 75% CSs to be performed under RA.1
We wished to know the extent to which RA was being used
in the Free State and at which hospitals. This was so that
institutions where the 75% target was not being achieved could
be identified and measures then considered, where
appropriate, to achieve the recommended target. 
The study was retrospective and identified the types of
anaesthesia administered to patients receiving a CS in level 1
and 2 hospitals in the Free State, from 1 September 2002 to 30
November 2002. The study method was to visit each hospital in
December 2002 or January 2003 and retrieve the information
from theatre record books.
In our results, both spinal and epidural (only 4 patients)
techniques were recorded as RA; patients who required a
general anaesthetic due to a failed spinal were also recorded
under RA, as at least this had been attempted.
The results were as follows. During the 3-month study
period, CSs were performed in 19/24 level 1 hospitals and all 5
level 2 hospitals in the Free State. A total of 1 734 CSs were
performed. For 5 patients there was a failure to record the type
of anaesthesia. Of the remaining 1 729 CSs, 1 231 (71.2%) were
performed using RA.
The data for each hospital are presented in Table I.
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Table I. Types of anaesthesia administered for caesarean sections in Free State level 1 and 2 hospitals from 1 September 2002 to 30 November
2002 (new names of hospitals in brackets)
Not
Level Name of hospital RA GA Total recorded % RA use 95% CI
1 Bothaville (Nala) 0 17 17 0 0 0; 19.5
1 Jagersfontein (Diamond) 0 8 8 0 0 0; 36.9
1 Ladybrand (Mantsopa) 0 13 13 0 0 0; 24.7
1 Winburg 0 9 9 0 0 0; 33.6
1 Odendaalsrus (Thusanong) 5 76 81 0 6.2 2.0; 13.8
1 Heilbron (Tokollo) 2 26 28 0 7.1 0.9; 23.5
1 Clocolan (John Daniel Newsberry) 3 15 18 0 16.7 3.6; 41.4
1 Frankfort (Mafube) 15 23 38 1 39.5 24.0; 56.6
1 Sasolburg (Metsimaholo) 64 44 108 0 59.3 50.0; 68.5
1 Harrismith (Thebe) 29 16 45 0 64.4 48.8; 78.1
1 Senekal 11 3 14 0 78.6 49.2; 95.3
1 Moroka (Dr J S Moroka) 45 11 56 0 80.4 67.6; 89.8
1 Reitz (Nketoana) 15 3 18 0 83.3 58.6; 96.4
1 Bothshabelo 111 11 122 0 91.0 84.4; 95.4
1 Ficksburg (Phuthuloha) 20 2 22 0 90.9 70.8; 98.9
1 National 26 2 28 0 92.9 76.5; 99.1
1 Parys 20 1 21 0 95.2 76.2; 99.9
1 Phekolong 23 0 23 0 100.0 85.2; 100
1 Virginia (Katleho) 1 0 1 0 100.0 *
2 Manapo (Mofumahadi Manapo Mopeli) 139 58 197 0 70.6 64.2; 76.9
2 Goldfields (Bongani) 162 60 222 0 73.0 67.1; 78.8
2 Bethlehem (Dihlabeng) 90 23 113 0 79.6 72.2; 87.1
2 Boitumelo 123 22 145 2 84.8 79.0; 90.7
2 Pelonomi 327 55 382 2 85.6 82.1; 89.1
Total 1 231 498 1 729 5 71.2 69.1; 73.3
* Cannot be calculated.
RA = regional anaesthesia: GA = general anaesthesia.
Overall we found that the 75% RA use target was achieved
in 3/5 level 2 hospitals (60%) and 9/19 (47%) level 1 hospitals
in the Free State.
It was noted that there were 6 hospitals in which RA is not
used, or rarely used (< 10% of cases). In one of these,
Odendaalsrus, a relatively large number of CSs were
performed (81 cases).
This is the first survey we are aware of that has
quantitatively investigated which type of anaesthetic is used
for CS in South Africa. The information obtained is being used
to help us construct training programmes in RA, aimed at
those institutions where RA is being relatively underutilised.
This study was funded by the Free State Provincial Department
of Health.
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